Sirio Pharma Co.,Ltd.’s Net Profit Dropped 9.3% in First Three Quarters of 2023

Sirio Pharma Co.,Ltd. (仙乐健康科技股份有限公司) (300791.SZ) reported a net profit of 159.7 million yuan in the first three quarters of 2023, down 9.3% year-on-year.

Meanwhile, the company posted 2.5 billion yuan in revenue, up 40% year-on-year.

At the end of the reporting period, it had 4.9 billion yuan in total assets and 1.9 billion yuan in total liabilities, with a liability-to-asset ratio of 39.3%.